Previous 10 | Next 10 |
home / stock / nonof / nonof news
2024-02-20 11:00:28 ET Summary Healthcare stocks have seen a better 2024 so far this year than the entire 2023 and 2022 years combined. If you go back 2 calendar years, the broad-based Health Care Select Sector SPDR® Fund ETF was still down slightly on a total-return basis. B...
2024-02-16 07:15:34 ET More on Eli Lilly Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Eli Lilly: Overvaluation Is A Big Red Flag Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly obesity therapy tirzepatide being rolled out in...
2024-02-15 02:45:18 ET Summary Novo Nordisk's weight loss drug, Wegovy, shows potential for reducing cardiovascular risks by 20% in overweight or obese individuals. The company is actively working to scale up production of Wegovy to meet increasing demand and decrease cost per uni...
2024-02-14 17:35:57 ET Summary Novo Nordisk reported great results for fiscal 2023 with the top and bottom line growing in the higher double-digits. Growth was especially driven by Wegovy and Ozempic, and management is also optimistic for fiscal 2024. Novo Nordisk is trading f...
2024-02-13 13:07:35 ET More on Eli Lilly Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade) Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript Federal judge...
2024-02-12 21:01:27 ET More on Bristol-Myers Squibb Company , Eli Lilly, etc. Pfizer Stock: It's Time To Buy The Dip Pfizer Is A Great Investment Over The Next Decade; Buy Will Eli Lilly and Company Become A Trillion-Dollar Baby? RayzeBio ticks higher af...
2024-02-12 08:41:44 ET More on Novo Nordisk Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Booming weight-loss drug market to lift “pick-and-shovel...
2024-02-11 12:00:03 ET More on Eli Lilly, Novo Nordisk, etc. Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade) Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript ...
2024-02-07 18:00:06 ET Summary Eli Lilly and Company has seen significant growth and generated strong returns, outperforming the S&P 500. The company's revenue increased by 28.1% in the final quarter of 2023, exceeding analysts' expectations. While some drugs, like Trulici...
2024-02-07 13:52:09 ET More on Novo Nordisk Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Lilly reportedly worried about impact of Catalent/Novo deal ...
News, Short Squeeze, Breakout and More Instantly...
Partnership will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation and cell therapy development and manufacturing . Aspect to receive 75 million US dollars in initial payments and u...
New York City, NY: May 06, 2020 – Published via (Wired Release):- “Market.us presents a new report titled Alkyl Benzyl Dimethyl Ammonium Chloride Market: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information...